Search
Citius Oncology Inc
CTORAdd to Watchlist
0.562USD
-0.016-2.77%
Close 07-24 16:00（ET）Quotes delayed by 15 min
52.27MMarket Cap
LossP/E TTM
Citius Oncology Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Citius Oncology Inc is 7.39, ranking 242 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.17, which is -44.31% below the recent high of -0.65 and -173.45% above the recent low of -3.20.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.